PO-0960: Radiobiological effectiveness and its role in modelling secondary cancer risk for proton therapy

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{19496683915d4cb289077c5c6fc4628d,

title = "PO-0960: Radiobiological effectiveness and its role in modelling secondary cancer risk for proton therapy",

author = "Y Keisari and R Etzyoni and H Bittan and E Lazarov and M Efrati and M Schmidt and T Cooks and L Arazi and I Kelson",

year = "2017",

language = "English",

volume = "123",

pages = "S530--S531",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - PO-0960: Radiobiological effectiveness and its role in modelling secondary cancer risk for proton therapy

AU - Keisari, Y

AU - Etzyoni, R

AU - Bittan, H

AU - Lazarov, E

AU - Efrati, M

AU - Schmidt, M

AU - Cooks, T

AU - Arazi, L

AU - Kelson, I

PY - 2017

Y1 - 2017

M3 - Article

SN - 0167-8140

VL - 123

SP - S530-S531

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

ER -